Investors

Plus Therapeutics (PSTV on Nasdaq) is a U.S. clinical-stage pharmaceutical company, backed by talented executives and a nationwide network of scientists, engineers and physicians.

With a hybrid virtual drug development model, we are well-positioned to be capital efficient, enhance operational efficiencies, decrease costs, and accelerate product development. We are headquartered in Austin, Texas, with additional laboratories and state-of-the-art clean rooms in San Antonio, Texas in order to undertake key preclinical and other development work.

Our location provides us with many strategic advantages, including proximity to world-class cancer institutions and researchers – as well as the ability to qualify and apply for funding through the Cancer Prevention and Research Institute of Texas (CPRIT).